Latest news
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:01:00 GMTThree New Hires Receive Stock Awards With Up to 4-Year Vesting - Stock TitanStock Titan · Thu, 06 Aug 2026 20:01:00 GMTFMR LLC and Abigail Johnson report 10.3M-share Pharma Company NV (NAMS) stake - Stock TitanStock Titan · Thu, 06 Aug 2026 14:34:54 GMTNewAmsterdam Pharma Company N.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 15:53:29 GMTNewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:55:03 GMTNewAmsterdam Pharma Company N.V. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 12:46:24 GMTNewAmsterdam Pharma reports $3.7 million second quarter revenue - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:16:00 GMTNewAmsterdam reports $64.1M Q2 net loss, $678.3M cash; CHMP recommends obicetrapib approval - TradingViewTradingView · Wed, 05 Aug 2026 11:13:00 GMT